within Pharmacolibrary.Drugs.S_SensoryOrgans.S01B_AntiinflammatoryAgents.S01BC01_Indometacin;

model Indometacin
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C_enteral(
    weight = 70,
    F = 0.9,
    Cl = 9.13888888888889e-07,
    adminDuration = 600,
    adminMass = 50 / 1000000,
    adminCount = 1,
    Vd = 0.00034,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.005833333333333333,
    Tlag = 900,
    Vdp = 0.00014000000000000001,
    k12 = 2.1388888888888888e-07,
    k21 = 2.1388888888888888e-07);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Indometacin</td></tr><tr><td>ATC code:</td><td>S01BC01</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>50</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.34</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.047</td><td>L/h/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Indometacin (also known as indomethacin) is a non-steroidal anti-inflammatory drug (NSAID) used primarily to reduce fever, pain, stiffness, and swelling from inflammation. It is used to treat conditions such as rheumatoid arthritis, osteoarthritis, gout, and ankylosing spondylitis, as well as certain ophthalmic indications. The drug is approved and currently used in various oral and ophthalmic formulations.</p><h4>Pharmacokinetics</h4><p>PK parameters reported for healthy adult volunteers after oral administration.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.S.S01BC01 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Indometacin;
